Appeals court upholds FTC ruling against Impax Labs
There was more than enough evidence for the Federal Trade Commission to rule that Impax Laboratories accepted illegal payments to delay the entry of an opioid painkiller for more than two...To view the full article, register now.
Already a subscriber? Click here to view full article